enzymelink
immunosorh
assay
elisa
detect
rhinoviru
specif
antibodi
human
sera
nasal
secret
develop
sandwich
elisa
util
rabbit
antirhinoviru
hyperimmun
serum
captur
antibodi
found
sensit
detect
rhinoviru
specif
antibodi
serum
dilut
igg
iga
immunoglobulin
respect
thu
new
assay
time
sensit
standard
neutral
test
furthermor
increas
sensit
enabl
us
reliabl
detect
rhinoviru
specif
immunoglobulin
unconcentr
nasal
wash
thought
particularli
import
protect
rhinoviru
reinfect
preliminari
studi
immun
respons
human
volunt
challeng
rhinoviru
use
new
elisa
system
present
applic
potenti
method
also
discuss
specif
antibodi
produc
rhinoviru
infect
routin
detect
abil
neutral
viru
tissu
cultur
consequ
measur
antibodi
depend
viru
isol
costli
timeconsum
spite
neutral
test
use
epidemiolog
studi
fox
et
al
laboratori
diagnosi
recent
rhinoviru
infect
hamparian
epidemiolog
studi
reveal
larg
proport
infect
individu
shed
viru
show
serolog
respons
neutral
antibodi
fox
et
al
furthermor
studi
laboratori
indic
mani
volunt
becom
infect
follow
rhinoviru
challeng
even
though
serum
neutral
antibodi
ws
barclay
unpublish
data
earlier
studi
indic
local
antibodi
nasal
secret
measur
neutral
reliabl
indic
rhinoviru
immun
statu
circul
antibodi
cate
et
al
howev
neutral
test
lack
sensit
reliabl
detect
antibodi
nasal
wash
haemagglutinationinhibit
test
develop
detect
serum
nasal
secret
antibodi
rhinovirus
prior
concentr
nasal
wash
still
requir
detect
local
antibodi
reed
hall
furthermor
rhinoviru
serotyp
haemagglutin
latter
test
gain
widespread
use
therefor
develop
enzymelink
immunosorb
assay
elisa
detect
rhinoviru
classspecif
antibodi
serum
nasal
secret
studi
describ
new
assay
applic
studi
immun
respons
follow
inocul
rhinoviru
rhinoviru
use
studi
untyp
human
rhinovirusel
hrvel
although
member
rhinoviru
genu
physic
biochem
criteria
hrvel
assign
serotyp
number
collabor
scheme
howev
cross
neutral
test
laboratori
suggest
hrvel
antigen
relat
c
dearden
unpublish
data
hrvel
grown
high
titr
infect
confluent
monolay
ohio
hela
cell
ml
medic
flat
overlaid
ml
hela
mainten
medium
bme
contain
foetal
calf
serum
tryptos
phosphat
broth
antibiot
nah
co
mm
mgcl
appear
cytopath
effect
cell
frozen
thaw
rapidli
time
centrifug
rpm
min
remov
cell
debri
crude
tissu
cultur
fluid
contain
viru
harvest
store
control
antigen
prepar
way
except
cell
infect
viru
antigen
immun
purifi
fluorocarbon
extract
thu
volum
arklon
ici
ad
volum
crude
antigen
mixtur
shaken
room
temperatur
centrifug
rpm
min
aqueou
layer
harvest
centrifug
rpm
h
viru
pellet
resuspend
small
volum
tri
buffer
ph
mix
equal
volum
freund
incomplet
adjuv
rabbit
immun
follow
short
schedul
ml
emuls
least
pfu
intramuscularli
hind
leg
follow
ml
viru
intraven
week
later
anim
bled
week
hyperimmun
serum
found
neutral
titr
tcid
homolog
viru
twentyon
volunt
inocul
intranas
hrvel
common
cold
unit
took
part
separ
trial
zerial
et
al
provid
sampl
studi
thu
serum
sampl
collect
viru
challeng
week
later
nasal
wash
collect
day
viru
inocul
accord
standard
procedur
common
cold
unit
ie
ml
hank
balanc
salt
solut
instil
nostril
expel
fluid
mix
equal
volum
nutrient
broth
viru
nasal
wash
isol
ohio
hela
cell
sampl
antibodi
measur
heat
min
store
basi
clinic
score
measur
sever
symptom
assess
unit
viru
isol
seroconvers
shown
greater
increas
neutral
antibodi
titr
preand
postinfect
sera
volunt
divid
group
thu
first
group
volunt
show
symptom
common
cold
clinic
score
lo
also
shed
viru
nasal
secret
term
group
cold
second
group
volunt
although
infect
show
symptom
clinic
score
shed
viru
andor
show
seroconvers
term
group
infect
cold
rest
volunt
despit
challeng
show
clinic
laboratori
evid
infect
term
third
group
infect
igg
produc
goat
conjug
alkalin
phosphatas
mile
laboratori
use
dilut
looo
phosphat
buffer
salin
contain
tween
sigma
chemic
co
pbst
bovin
serum
albumin
bsa
similarli
antihuman
iga
produc
goat
conjug
alkalin
phosphatas
sigma
chemic
co
dilut
looo
diluent
antirabbit
igg
produc
goat
conjug
alkalin
phosphatas
mile
laboratori
use
dilut
also
pbst
contain
bsa
alkalin
phosphatas
substrat
pnitrophenol
phosphat
sigma
chemic
co
one
mgiml
dissolv
diethanolamin
buffer
polystyren
roundbottom
micro
elisa
plate
nunc
immunopl
u
type
ii
incub
overnight
per
well
dilut
rabbit
hyperimmun
antirhinovirusel
serum
carbonatebicarbon
buffer
ph
well
drain
uncoat
site
nonspecif
bind
might
occur
block
bsa
pb
h
plate
wash
time
pbst
one
hundr
dilut
crude
viru
antigen
infect
tcid
per
ml
control
antigen
pbst
contain
bsa
uninfect
tissu
cultur
fluid
ad
plate
incub
overnight
wash
test
sampl
variou
serial
dilut
diluent
ad
incub
h
plate
wash
appropri
conjug
ad
incub
h
final
plate
wash
time
pbst
substrat
ad
well
plate
left
uncov
room
temperatur
optic
densiti
nm
read
variou
time
interv
titertek
multiskan
elisa
reader
flow
laboratori
well
roundbottom
micro
elisa
plate
nunc
immunopl
u
type
ii
coat
overnight
lo
dilut
viru
antigen
partial
purifi
peg
precipit
ultracentrifug
sucros
densiti
gradient
start
materi
purif
infect
tcid
per
ml
plate
drain
quench
bsa
pb
elisa
procedur
point
ad
test
sampl
sandwich
elisa
sera
test
duplic
lofold
serial
dilut
nasal
wash
duplic
serial
dilut
mean
duplic
correct
dilut
subtract
mean
optic
densiti
od
absenc
sampl
valu
od
control
antigen
coat
well
correct
way
subtract
correct
od
plot
log
sampl
dilut
gener
sigmoid
curv
assay
line
chosen
od
level
intersect
curv
linear
portion
major
sampl
elisa
titr
taken
reciproc
sampl
dilut
correspond
od
neutral
antibodi
detect
standard
microneutr
test
use
common
cold
unit
briefli
serial
dilut
serum
incub
tcid
viru
per
well
h
room
temperatur
x
ohio
hela
cell
hela
mainten
medium
contain
foetal
calf
serum
ad
plate
incub
day
read
microscop
cpe
neutral
titr
reciproc
lowest
serum
dilut
neutral
tcid
viru
viru
titrat
cell
control
includ
everi
test
fig
la
show
measur
hrvel
specif
igg
rabbit
preand
postimmun
sera
indirect
elisa
compar
measur
hrvel
specif
igg
iga
preand
postinfect
human
sera
method
fig
lb
c
illustr
indirect
elisa
detect
high
titr
hrvel
specif
antibodi
preand
postinfect
human
sera
henc
fail
show
specif
antibodi
respons
follow
hrvel
infect
although
individu
found
excret
viru
show
serolog
evid
infect
neutral
test
symptom
common
cold
contrast
sandwich
elba
fig
ld
e
demonstr
increas
hrvel
specif
antibodi
infect
igg
iga
class
immunoglobulin
sera
individu
howev
noteworthi
titr
hrvel
specif
igg
preinfect
serum
high
rise
much
follow
infect
iga
class
fig
show
titrat
curv
igg
fig
c
iga
fig
immunoglobulin
specif
hrvel
postinfect
sera
fig
b
nasal
secret
fig
infect
volunt
symptomat
measur
sandwich
elisa
od
valu
obtain
control
antigen
coat
well
low
independ
sampl
dilut
indic
test
specif
detect
antibodi
viru
highest
dilut
hrvel
specif
serum
antibodi
detect
l
lo
igg
iga
respect
neutral
antibodi
titr
serum
sampl
addit
neutral
test
fail
detect
hrvel
specif
antibodi
postinfect
nasal
wash
sampl
yet
sandwich
elisa
detect
hrvel
specif
igg
iga
sampl
dilut
lo
volunt
challeng
hrvel
becam
infect
symptomat
cold
group
infect
asymptomat
infect
cold
group
show
clinic
laboratori
evid
infect
infect
group
volunt
chosen
studi
wide
rang
respons
hrvel
challeng
repres
group
titr
variou
irnmunoglobulin
specif
hrvel
measur
sandwich
elba
fig
show
geometr
mean
titr
rhinoviru
specif
antibodi
measur
elisa
microneutr
test
pair
sera
volunt
group
figur
suggest
detect
hrvel
specif
iga
measur
elisa
fig
better
indic
group
suscept
infect
detect
specif
igg
fig
neutral
antibodi
fig
thu
gmt
preinfect
hrvel
specif
serum
iga
much
higher
among
volunt
despit
challeng
becom
infect
among
volunt
becom
infect
furthermor
infect
gmt
hrvel
specif
iga
neutral
antibodi
show
substanti
rise
sera
volunt
becam
infect
wherea
gmt
hrvel
specif
igg
show
small
rise
follow
challeng
among
symptomat
volunt
inde
level
preexist
hrvel
specif
igg
gener
high
neither
correl
serum
neutral
antibodi
rise
appear
relev
protect
viru
challeng
fig
show
mean
od
obtain
nasal
wash
volunt
group
collect
day
inocul
test
dilut
sandwich
elisa
hrvel
specif
igg
iga
mean
od
valu
group
show
distinct
pattern
thu
volunt
infect
becam
symptomat
fig
show
hrvel
specif
increas
igg
iga
immunoglobulin
class
infect
contrast
volunt
becom
infect
fig
f
higher
level
local
rhinoviru
specif
iga
day
challeng
fell
fol
fig
time
cours
appear
hrvel
specif
igg
ac
iga
df
immunoglobulin
nasal
secret
day
hrvel
inocul
mean
od
obtain
nasal
wash
dilut
read
min
substrat
addit
shown
volunt
respons
group
cold
ad
infect
cold
infect
cf
bar
repres
standard
error
mean
low
day
hand
volunt
subclin
infect
fig
e
show
intermedi
chang
specif
iga
level
littl
hrvel
specif
igg
agreement
sandwich
elisa
neutral
rest
data
tabl
show
hrvel
antibodi
titr
pair
sera
individu
volunt
measur
elba
neutral
test
differ
titr
infect
measur
elba
igg
neutral
test
compar
rank
coeffici
correl
indic
agreement
two
measur
similar
analysi
elba
iga
measur
neutral
antibodi
titr
differ
gave
r
valu
illustr
although
agreement
better
elisa
igg
measur
nonetheless
incomplet
elisa
describ
studi
simpl
rapid
assay
detect
rhinoviru
classspecif
immunoglobulin
serum
nasal
secret
extrem
sensit
techniqu
detect
hrvel
specif
igg
iga
antibodi
postinfect
serum
dilut
lo
lo
fold
greater
respect
endpoint
dilut
neutral
test
unconcentr
nasal
wash
ing
consist
detect
hrvel
specif
antibodi
igg
iga
class
wherea
neutral
test
lack
sensit
reliabl
detect
local
specif
antibodi
feel
import
featur
rhinoviru
elisa
system
sinc
possibl
look
close
immun
respons
follow
rhinoviru
infect
perhap
abl
identifi
featur
humor
immun
respons
may
relev
protect
reinfect
homolog
heterolog
viru
inde
preliminari
data
present
studi
suggest
presenc
rhinoviru
specif
iga
serum
nasal
secret
appear
import
protect
reinfect
presenc
specif
igg
thu
group
volunt
show
evid
infect
despit
challeng
hrvel
infect
group
high
level
hrvel
specif
iga
sera
nasal
secret
furthermor
show
rise
specif
serum
igg
iga
neutral
antibodi
contrast
volunt
becam
subclin
infect
infect
cold
group
low
level
hrvel
specif
iga
serum
nasal
secret
infect
show
rise
specif
serum
iga
neutral
antibodi
infect
addit
volunt
becam
infect
symptomat
cold
group
also
low
level
preinfect
specif
iga
show
rise
specif
serum
igg
iga
neutral
antibodi
well
specif
igg
iga
nasal
secret
infect
data
demonstr
potenti
elba
detect
differ
compon
humorai
immun
respons
follow
rhinoviru
infect
may
import
vaccin
rhinoviru
infect
contempl
howev
view
fact
number
volunt
studi
small
per
group
confirm
elabor
find
await
much
larger
studi
need
involv
mani
volunt
present
elisa
data
obtain
serum
specimen
ideal
collect
measur
neutral
antibodi
titr
ie
prechalleng
serum
specimen
anoth
week
later
henc
measur
made
sampl
may
optim
detect
antibodi
rise
elisa
also
nasal
wash
use
studi
collect
primarili
viru
isol
antibodi
measur
therefor
specimen
also
probabl
optim
measur
sequenti
appear
declin
variou
rhinoviru
specif
immuoglobuiin
furthermor
seri
preinfect
nasal
wash
would
ideal
requir
establish
presenc
daytoday
variat
preexist
local
specif
antibodi
sinc
rhinoviru
infect
local
shortliv
present
rel
light
antigen
load
expect
sensit
assay
elisa
would
detect
rapid
immunoglobulin
respons
soon
inocul
rather
week
later
inde
use
elisa
system
detect
classspecif
respons
respiratori
virus
parainfluenza
viru
influenza
viru
indic
respons
appear
within
day
onset
symptom
van
der
logt
et
al
leinikki
passila
therefor
possibl
studi
miss
peak
rhinoviru
specif
immunoglobulin
respons
least
serum
plan
extens
detail
studi
human
volunt
wherebi
close
